Apoptosis in neuroendocrine tumours

Clinical Endocrinology

Volumn 51, Issue 1, 1999, Pages 1-9

  Wang, Da Gong ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

APOPTOSIS; CELL DEATH; CELL PROLIFERATION; CLONAL ANERGY; EMBRYO DEVELOPMENT; GENETIC REGULATION; MOLECULAR CLONING; NEUROENDOCRINE TUMOR; ONCOGENE C MYC; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

APOPTOSIS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION; GENES, P53; HUMANS; MUTATION; NEUROENDOCRINE TUMORS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 0032771038     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1999.00756.x     Document Type: Review

References (123)

1. Barge, R.M.Y., Willemze, R., Vandenabeele, P., Fiers, W. & Beyaer, R. (1997) Differential involvement of caspases in apoptosis of myeloid leukemic cells induced by chemotherapy versus growth factor withdrawal. FEBS Letters, 409, 207-210.
2. Basolo, F., Pollina, L., Fontanini, G., Fiore, F., Pacini, F. & Baldanzi, A. (1997) Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression. British Journal of Cancer, 75, 537-541.
3. Ben-Ezra, J.M., Kornstein, M.J., Grines, M.M. & Krystal, G. (1994) Small cell carcinomas of the lung express the Bcl-2 protein. American Journal of Pathology, 145, 1036-1040.
4. Benker, G., Dabag, S. & Reinwein, D. (1981) Chemotherapy of thyroid carcinoma: Benefits and side-effects. In: Advances in Thyroid Neoplasia (Eds. M. Andreal, F. Monaco & J. Robbins), pp. 262-274. Field Educational Italia, Rome.
5. Bohmann, D., Bos, T.J., Admon, A., Nishimura, T., Vogt, P.K. & Tjian, R. (1987) Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science, 238, 1386-1392.
6. Bolande, R. (1974) The neurocrestopathies: a unifying concept of disease arising from neural crest maldevelopment. Human Pathology, 5, 409-415.
7. Brambilla, E., Negoescu, A., Gazzeri, S., Lantuejoul, S., Moro, D., Brambilla, C. & Coll, J.L. (1996) Apoptosis-related factors p53, Bcl-2, and Bax in neuroendocrine lung tumors. American Journal of Pathology, 149, 1941-1952.
8. Campos, L., Rouault, J.P., Sabido, O., Oriol, P., Roubi, N., Vasselon, C., Archimbaud, E., Magaud, J.P. & Guyotat, D. (1993) High expression of bcl-2 protein in acute myeloid leukaemia cells is associated with poor response to chemotherapy. Blood, 81, 3091-3096.
9. Caron, H., van Sluis, P., van Hoeve, M., Dekraker, J., Bras, J., Slater, R., Mannens, M., Voute, P.A., Westerveld, A. & Versteeg, R. (1993) Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with MYCN amplification. Nature, Genetics, 4, 187-190.
10. Castle, V.P., Heidelberger, K.P., Bromberg, J., Ou, X., Dole, M. & Nunez, G. (1993) Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfovourable histology and N-myc amplification. American Journal of Pathology, 143, 1543-1550.
11. Castresana, J.S., Bello, M.J., Reu, J.A., Nebreda, P., Queizan, A., Garcia-Miguel, P. & Pestana, A. (1994) No TP. 53 mutations in neuroblastomas detected by PCR-SSCP analysis. Genes Chromosomes Cancer, 10, 136-138.
12. Cerreti, D.P., Kozlosky, C.J., Molsey, B., Nelson, N., Ness, K.V., Greenstreet, T.A., March, C.J., Kronheim, S.R., Druck, T., Cannizarro, L.A., Huebner, K. & Black, R.A. (1992) Molecular cloning of the interleukin-1ß converting enzyme. Science, 256, 97-100.
13. Chandrasekharappa, S., Guru, S., Manickam, P., Olufemi, S.E., Collins, F.S., Emmert-Buck, M.R., Debelenko, L.V., Zhuang, Z., Lubensky, I.A., Liotta, L.A., Crabtree, J., Wang, Y., Roe, B., Weisemann, J., Boguski, M., Agawal, S., Kester, M.B., Kim, Y., Heppner, C., Dong, Q., Spiegel, A.M., Burns, A.L. & Marx, S.J. (1997) Positional cloning of the gene for multiple endocrine neoplasia 1. Science, 276, 404-407.
14. Cidlowski, J.A., King, K.L., Evans-Storms, R.B., Montague, J.W., Bortner, C.D. & Hughes, P.M. (1996) The biochemistry and molecular biology of glucocorticoid-induced apoptosis in the immune system. Recent Progress in Hormone Research, 51, 457-491.
15. Dahia, P.L.M., Aguiar, R.C.T., Tsanaclis, A.M., Bendit, I., Bydlowski, S.P., Abelin, N.M.A. & Toledo, A.P.A. (1995) Molecular and immunohistochemical analysis of p53 in phaeochromocytoma. British Journal of Cancer, 72, 1211 -1213.
16. Debelenko, L.V., Emmert-Buck, M.R., Zhuang, Z., Epshteyn, E., Moskaluk, C.A., Jensen, R.T., Liotta, L.A. & Lubensky, I.A. (1997a) The multiple endocrine neiplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology, 113, 773-781.
17. Debelenko, L.V., Zhuang, Z., Emmer-Buck, M.R., Chandrasekharappa, S.C., Manickam, P., Guru, S.C., Marx, S.J., Skarulis, M.C., Spiegel, A.M., Collins, F.S., Jensen, R.T., Liotta, L.A. & Lubensky, I.A. (1997b) Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1 associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Research, 57, 2238-2243.
18. Eng, C. (1996) The RET. proto-oncogene in multiple endocrine neoplasia type 2 and hirschsprung's disease. New England Journal of Medicine, 335, 943-951.
19. Eng, C. & Mulligan, L.M. (1997) Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease. Human Mutation, 9, 97-109.
20. Estus, S.E., Zaks, W.J., Freeman, R.S., Gruda, M., Bravo, R. & Johnston, E.M. (1994) Altered gene expression in neurones during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis. Journal of Cell Biology, 127, 1717-1712.
21. Evan, G.I., Wyllic, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z. & Hancock, D.C. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128.
22. Evans-Storms, R.B. & Cidlowski, J.A. (1995) Regulation of apoptosis by steroid hormones. Journal of Steroid Biochemistry and Molecular Biology, 53, 1-8.
23. Fanidi, A., Harrington, E.A. & Wvan, G.I. (1992) Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature, 359, 554-556.
24. Ferrer, I., Segui, J. & Olive, M. (1996) Strong c-Jun immunoreactivity is associated with apoptotic cell death in human tumors of the central nervous system. Neuroscience Letters, 16, 49-52.
25. Fisher, T.C., Milner, A.E., Gregory, C.D., Jackman, A.L., Aherne, G.W., Hartley, J.A., Dive, C. & Hickman, J.A. (1993) Bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Research, 53, 3321-3326.
26. Gottlieb, J.A., Hill, C.S. Jr, Ibanez, M.L. & Clark, R.E. (1972) Chemotherapy of thyroid cancer: an evaluation of experience with 37 patients. Cancer, 30, 848-853.
27. Griffith, T.S., Brunner, T. & Flercher, S.M. (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science, 270, 1189-1192.
28. Hahne, M., Rimoldi, D., Schroter, P., Romero, P., Schreier, M., French, L.E., Schneider, P., Bornand, T., Fontana, A., Licnard, D., Cerottini, J.C. & Tschopp, J. (1996) Melanoma cell expression of Fas (Apo-1/ CD95) ligand: implications for tumor immune escape. Science, 274, 1302-1363.
29. Hakin, J.P. & Levine, M.A. (1994) Absence of p53 point mutations in parathyroid adenoma and carcinoma. Journal of Clinical Endocrinology and Metabolism, 78, 103-106.
30. Hartmann, A., Blaszyk, H., Cunningham, J.S., McGovern, R.M., Schroeder, J.S., Helander, S.D., Pittelkow, M.R., Sommer, S.S. & Kovach, J.S. (1996) Overexpression and mutations of p53 in metastatic malignant melanomas. International Journal of Cancer, 67, 313-317.
31. Hazard, J.B. (1977) The C. -cell parafollicular cells of the thyroid gland carcinoma. American Journal of Pathology, 88, 214-249.
32. Hengartner, M.O., Ellis, R.E. & Horvitz, R.H. (1992) Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature, 356, 494-499.
33. Hengartner, M.O. & Horvitz, R. (1994) C. elegans cell survival gene ced-9 encodes a functional homologue of the mamalian proto-oncogene bcl-2. Cell, 76, 665-676.
34. Heppner, C., Kester, M.B., Debelenko, L.V., Emmert-Buck, M.R., Guru, S.C., Manickam, P., Olufemi, S.E., Skarulis, M.C., Doppman, J.L., Alexander, R.H., Kim, Y.S., Saggar, S.K., Lubensky, I.A., Zhuang, Z., Liotta, L.A., Chandrasekharappa, S.C., Collins, F.S., Spiegel, A.M., Burns, A.L. & Marx, S.J. (1997) Somatic mutation of the MEN1 gene in parathyroid tumours. Nature Genetics, 16, 375-378.
35. Herman, V., Drazin, N.Z., Gonsky, R. & Melmed, S. (1993) Molecular screening of pituitary adenomas for gene mutations and rearrangements. Journal of Clinical Endocrinology and Metabolism, 77, 50-55.
36. Hermeking, H. & Eick, D. (1994) Mediation of c-Myc-induced apoptosis by p53. Science, 265, 2091-2093.
37. Hickman, J.A. (1992) Apoptosis induced by anticancer drugs. Cancer and Metastasis Reviews, 11, 121-139.)
38. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R.D. & Korsmeyer, S.J. (1990) Bcl-2 is an inner mitochondria membrane protein that blocks programmed cell death. Nature, 348, 334-336.
39. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C.C. (1991) p53 mutations in human cancer. Science, 253, 49-53.
40. Hsu, S.Y. & Hsuch, A.J.W. (1997) Hormonal regulation of apoptosis. Trends in Endocrinology and Metabolism, 8, 207-213.
41. Husain, M., Alsever, R.N., Lock, J.P., George, W. & Katz, F.H. (1978) Failure of medullary carcinoma of the thyroid to respond to doxorubicin therapy. Hormone Research, 9, 22-25.
42. Ikegaki, N., Katsumata, M., Tsujimoto, Y., Nukagawara, A. & Brodeur, G.M. (1995) Relationship between blc-2 and myc gene expression in human neuroblastoma. Cancer Letters, 91, 161-168.
43. Imam, H., Eriksson, B., Lukinius, A., Janson, E.T., Lindgren, P.G., Wilander, E. & Öberg, K. (1997) Induction of apoptosis in neruroendocrine tumors of the digestive system during treatment with somatostain analogs. Acta Oncologica, 36, 607-614.
44. Itoh, N. & Nagata, A. (1993) A. novel protein domain required for apoptosis. Mutation analysis of human Fas antigen. Journal of Biological Chemistry, 268, 10932-10937.
45. Jackson, C.E., Tashijian, A.H. Jr & Block, M.A. (1973) Detection of medullary thyroid cancer by calcitonin assay in families. American Internal Medicine, 78, 845-852.
46. Jiang, S.X., Kameya, T., Sato, Y., Yanase, N., Yoshimura, H. & Kodama, T. (1996) Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation. American Journal of Pathology, 148, 837-846.
47. Jiang, S.X., Sato, Y., Kuwao, A. & Kameya, T. (1995) Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas. Journal of Pathology, 177, 135-138.
48. Jost, C.A., Marin, M.C. & Kaelin, W.G. Jr (1997) p73 is a human p53-related protein that can induce apoptosis. Nature, 389, 191-194.
49. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.C., Valent, A., Minty, A., Chalon, P., Lelias, J.M., Dumont, X., Ferrara, P., McKeon, F. & Caput, D. (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90, 809-819.
50. Kato, H., Shichiri, M., Marumo, F. & Hirata, Y. (1997) Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology, 138, 2615-2620.
51. Kerr, J.F.R. & Harmon, B.V. (1991) Definition and incidence of apoptosis: an historical perspective. In: Apoptosis: the Molecular Basis of Cell Death (Eds. L.D. Tomei & F.O. Cope), pp. 5-29. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
52. Khosla, S., Oursler, M.J., Schroeder, M.J. & Eberhardt, N.L. (1994) Transforming growth factor β1 increases c-myc mRNA levels and induced growth inhibition and cell death of a human medullary thyroid carcinoma cell line. Endocrinology, 135, 1887-1893.
53. Kiess, W. & Gallaher, B. (1998) Hormonal control of programmed cell death/apoptosis. European Journal of Endocrinology, 138, 482-491.
54. Korsmeyer, S.J., Shutter, J.R., Veis, D.J., Merry, D.E. & Oltvai, Z.N. (1993) Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Seminars in Cancer Biology, 4, 327-332.
55. Korsmeyer, S.J. (1992) Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood, 80, 879-886.
56. Krajewski, S., Chatten, J., Hanada, M. & Reed, J.C. (1995) Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas: comparisons with tumour cell differentiation and N-Myc protein. Laboratory and Investigations, 71, 42-54.
57. Lane, D.P. (1992) Cancer-p53, guardian of the genome. Nature, 358, 15-16.
58. Langdon, W.Y., Harris, A.W., Cory, S. & Adams, J.M. (1986) The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice. Cell, 47, 11-18.
59. Lemmens, L., Van de Ven, W.J.M., Kas, K., Zhang, C.X., Giraud, S., Wautot, V., Buisson, N., Witte, K.D., Salandre, J., Lenoir, G., Pugeat, N., Calender, A., Parente, F., Quincey, D., Gaudray, P., De wit, M.J., Lips, C.J.M., Höppener, J.W.M., Khodaei, S., Grant, A.L., Weber, G., Kytölä, S., Teh, B.T., Farnebo, F., Phelan, C., Hayward, N., Larsson, C., Pannett, A.A.J., Forbes, S.A., Bassett, J.H.D. & Thakker, R.V. (1997) Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. Human Molecular Genetics, 6, 1177-1183.
60. Levy, A., Hall, L., Yeudall, W.A. & Loghman, S.L. (1994) p53 gene mutations in pituitary adenomas: rate events. Clinical Endocrinology, 41, 809-814.
61. Lindenboim, L., Haviv, R. & Stein, R. (1995) Inhibition of drug-induced apoptosis by survival factors in PC12 cells. Journal of Neurochemistry, 64, 1054-1063.
62. Liu, X., Kim, C.N. & Yang, J. (1996) Induction of apoptic program in cell-free extracts: requirements for DATP and cytochrome c. Cell, 86, 147-157.
63. Lohmann, D.R., Fesseler, B., Pütz, B., Reich, U., Böhm, J., Präuer, H., Wünsch, P.H. & Höfler, H. (1993a) Infrequent mutations of the p53 gene in pulmonary carcinoid tumors. Cancer Research, 53, 5797-5801.
64. Lohmann, D.R., Funk, A., Niederneyer, H.P., Häupel, S. & Höfler, H. (1993b) Identification of p53 gene mutations in gastrointestinal and pancreatic carcinoids by nonradioisotopic SSCA. Virchows Archive B, 64, 293-296.
65. Lowe, S., Ruley, H.E., Jacks, T. & Housman, D.E. (1993) p53-depandent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 954-967.
66. Lubbe, J., Reichel, M., Burg, G. & Kleihues, P. (1994) Absence of p53 gene mutations in cutaneous melanoma. Journal of Investigative Dermatology, 102, 819-821.
67. Mah, S.P., Zhong, L.T., Liu, Y., Roghani, A., Wdwards, R.H. & Bredesen, D.E. (1993) The protooncogene bcl-2 inhibits apoptosis in PC12 cells. Journal of Neurochemistry, 60, 1183-1186.
68. McDonnell, T.J., Nunez, G., Platt, F.M., Hockenberry, D., London, L., McKearn, J.P. & Korsmeyer, S.J. (1990) Deregulated bcl-2-lg transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Molecular Cell Biology, 10, 1901-1907.
69. McDonnell, T.J. & Korsmeyer, S.J. (1991) Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice trasgenic for the t (14; 18). Nature, 349, 254-256.
70. McDonnell, T.J. (1993) Cell division versus cell death: a functional model of multistep neoplasia. Molecular Carcinogenesis, 8, 209-213.
71. Miracco, C., Santopietro, R., Biagioli, M., Lazzi, S., Nyongo, A., Vatti, R. & Luzi, P. (1998) Different patterns of cell proliferation and death and oncogene expression in cutaneous malignant melanoma. Journal of Cutaneous Pathology, 25, 244-251.
72. Miyashita, T. & Reed, J.C. (1995) Tumor suppresor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
73. Nunez, G., Seto, M., Seremetis, S., Ferreto, D., Grignani, F., Korsmeyer, S.J. & Dallafauera, R. (1989) Growth-promoting and tumor-promoting effects of deregulated bcl-2 in human B-lymphoblastoid cells. Proceedings of the National Academy of Sciences of the USA, 86, 4589-4593.
74. Owen-Schaub, L.B., Zhang, W. & Cusack, J.C. (1995) Wild-type p53 and a temperature-sensitive mutant induce Fas/Apo-1 expression. Molecular Cell Biology, 15, 3032-3040.
75. Pavelic, K., Hrascan, R., Kapitanovic, S., Karapandza, N., Vranes, Z., Belicza, M., Kruslin, B. & Cabrijan, T. (1995) Multiple genetic alterations in malignant metastatic insulinomas. Journal of Pathology, 177, 395-400.
76. Pearse, H. (1980) The APUD. system and hormone production. Clinical Endocrinology and Metabolism, 9, 211-223.
77. Prezant, T.R., Levine, J. & Melned, S. (1998) Molecular characterization of the men1 tumor suppressor gene in sporadic pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 83, 1388-1391.
78. Ramani, P. & Lu, Q.L. (1994) Expression of bcl-2 gene product in neuroblastoma. Journal of Pathology, 172, 273-278.
79. Reed, J.C. (1994) Bcl-2 and the regulation of programmed cell death. Journal of Cell Biology, 124, 1-6.
80. Reed, J.C., Cuddy, M., Haldar, S., Croce, C., Nowell, P., Makover, D. & Bradley, K. (1990) BCL-2 mediated tumorigenecity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL-2 antisense. Proceedings of the National Academy of Sciences of the USA, 87, 3660-3664.
81. Reed, J.C., Meister, L., Tanaka, S., Cuddy, M., Yun, S., Geyer, C. & Pleasure, D. (1993) Differential expression of bcl-2 protooncogene in neuroblastoma and other human tumor cell line of neural origin. Cancer Research, 51, 6529-6538.
82. Sakuta, H., Inaba, K. & Muramatsu, S. (1996) Calcitonin gene-related peptide enhances apoptosis of thymocytes. Journal of Neuroimmunology, 67, 103-109.
83. Sameshima, Y., Matsuno, Y., Hirohashi, S., Shimosato, T., Mizoguchi, H., Sugimura, T., Terada, M. & Yokota, J. (1992) Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene, 7, 451-457.
84. Schlingensiepen, K.H., Wollnik, F., Kunst, M., Schlingensiepen, R., Herdegen, T. & Brysch, W. (1994) The role of Jun transcription factor expression and phosphorylation in neuronal differentiation, neuronal cell death, and plastic adaptations in vivo. Cell Molecular Neurobiology, 14, 487-505.
85. Sentman, C.L., Shutter, J.R., Hockenbery, D., Kanagawa, O. & Korsmeyer, S.J. (1991) Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 67, 879-888.
86. Simizu, S., Umezawa, K., Takada, M., Arber, N. & Imoto, M. (1996) Induction of Hydrogen peroxide production and Bax expression by caspase-3(-like) proteases in tyrosine kinase inhibitor-induced apoptosis in human small cell lung carcinoma cells. Experimental Cell Research, 238, 197-203.
87. Strasser, A., Harris, A.W., Bath, M.L. & Coty, S. (1990) Novel primitive lymphoid tumors induced in transgenic mice by cooperation between myc and bcl-2. Nature, 348, 331-333.
88. Stretch, J.R., Gatter, K.C., Ralfkiaer, E., Lane, D.P. & Harris, A.L. (1991) Expression of mutant p53 in melanoma. Cancer Research, 51, 5976-5979.
89. Tahara, H., Smith, A.P., Gaz, R.D., Zariwala, M., Xiong, Y. & Arnold, A. (1997) Parathyroid tumor suppressor on lp: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate. Journal of Bone Mineral Research, 12, 1330-1334.
90. Takahashi, T., Takahashi, T., Suzuki, H., Hida, T., Sekido, Y., Ariyoshi, Y. & Ueda, R. (1991) The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene, 6, 1775-1778.
91. Tallett, A., Chilvers, E.R., Hannah, S., Dransfield, I., Lawson, M.F., Haslett, C. & Sethi, T. (1996) Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosion kinase activity stimulates apoptosis in small cell lung cancer cells. Cancer Research, 56, 4255-4256.
92. Tanaka, C., Kimura, T., Yang, P., Moritani, M., Yamaoka, T., Yamada, S., Sano, T., Yoshimoto, K. & Itakura, M. (1998) Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN 1 gene in sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 83, 2631-2634.
93. Tartaglia, L.A., Ayres, T.M., Wong, G.H. & Goeddel, D.V. (1993) A. novel domain within the 55-kd TNF receptor signals cell death. Cell, 74, 845-853.
94. Thompson, E.B. (1994) Apoptosis and steroid hormones. Molecular Endocrinology, 8, 665-673.
95. Thornberry, N.A., Bull, H.G., Calacay, J.R., Chapman, K.T., Howard, A.D., Kostura, M.J., Miller, D.K., Molineaus, S.M., Weidner, J.R., Aunins, J., Ellinston, K.O., Ayala, J.M., Casano, F.J., Chin, J., Jing, G.J.F., Egger, L.A., Gaffiney, E.P., Limjuco, G., Palyha, O.C., Raju, S.M., Rolando, A.M., Salley, J.P., Yamin, T.T., Lee, T.D., Shively, J.E., MaCross, M., Mumford, R.A., Schmidt, J.A. & Tocci, M.J. (1992) A. novel heterodimeric cysteine protease is required for interleukin-β processing in monocytes. Nature, 356, 768-774.
96. Uda, S., Yoshimura, A., Sugenoya, Y., Inui, K., Iwasaki, S., Taira, T. & Ideura, T. (1996) Role of apooptosis in the progression of secondary hyperparathyroidism. Nippon Jinzo Gakkai Shi, 38, 323-328.
97. van den Oord, J. J., Vandeghinste, N., De Ley, M. & De Wolf-Peeters, C. (1994) Bcl-2 expression in human melanocytes and melanocytic tumours. American Journal of Pathology, 145, 294-300.
98. Vargas, M.P., Vargas, H.I., Kleiner, D.E. & Merino, M.J. (1997) The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors. Modern Pathology, 10, 12-17.
99. Vaux, D.L. (1993) Toward an understanding of the molecular mechanisms of physiological cell death. Proceeding of the National Academy of Sciences of the USA, 90, 786-789.
100. Vaux, D.L., Cory, S. & Adama, J.M. (1988) bcl-2 gene promotes haemopoietic cell survival and cooperaties with c-myc to immortalize pre B cells. Nature, 335, 440-442.
101. Versteeg, R., Caron, H. & Cheng, N.C. (1995) van der Drift, P., Slater, R., Westerveld, A., Voute, P.A., Delattre, O., Laureys, G., van Roy, N. & Speleman, F. 1p36: Every subband a Suppressor? European Journal of Cancer, 31A, 538-541.
102. Viale, G., Roncalli, M., Grinelius, L., Graziani, D., Wilander, E., Johansson, H., Bergholm, U. & Coggi, G. (1995) Prognostic value of Bcl-2 immunoreactivity in medullary thyroid carcinoma. Human Pathology, 26, 945-950.
103. Vogan, K., Bernstein, M., Leclerc, J.M., Brisson, L., Brossard, J., Brodeur, G.M., Pelletier, J. & Gros, P. (1993) Absence of p53 gene mutations in primary neuroblastomas. Cancer Research, 53, 5269-5273.
104. Vogelstein, B. & Kinzler, K.W. (1992) p53 Function and dysfunction. Cell, 70, 523-526.
105. Wagner, A.J., Small, M.B. & Hay, N. (1993) Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2. Molecular Cell Biology, 13, 2432-2440.
106. Wang, D.G., Johnston, C.F., Anderson, N., Sloan, J.M. & Buchanan, K.D. (1995) Over-expression of ihe tumour suppressor gene p53 is not implicated in neuroendocrine tumour carcinogenesis. Journal of Pathology, 175, 397-401.
107. Wang, W., Johanson, H., Bergholm, U., Wilander, E. & Grimelius, L. (1996a) Apoptosis and expression of the proto-oncogenes bcl-2 and p53 and the proliferation factor Ki-67 in human medullary thyroid carcinoma. Endocrine Pathology, 7, 37-45.
108. Wang, D.G., Johnston, C.F., Atkinson, A.B., Heaney, A.P., Mirakhur, M. & Buchanan, K.D. (1996b) Expression Bcl-2 oncoprotein in human pituitary tumours: comparison with c-Myc. Journal of Clinical Pathology, 49, 795-797.
109. Wang, D.G., Barros D'Sa.A.A.B., Johnston, C.F. & Buchanan, K.D. (1996c) Oncogene expression in carotid body tumours. Cancer, 77, 2581-2587.
110. Wang, W., Johansson, H., Kvasnicka, T., Farnebo, L.O. & Grimelius, L. (1996d) Detection of apoptosis cells and expression of Ki-67 antigen, bcl-2, p53 oncoproteins in human parathyroid adenoma. APMIS, 104, 789-796.
111. Wang, D.G., Johnston, C.F., Marly, J.J., Phenix, K.V., Atkinson, A.B., Russell, C.F.J. & Buchanan, K.D. (1997a) Expression of the apoptosis suppressing gene bcl-2 in pheochromocytoma is associated with the expression of c-myc. Journal of Clinical Endocrinology and Metabolism, 82, 1949-52.
112. Wang, D.G., Johnston, C.F., Barros D'S.a.A.A.B. & Buchanan, K.D. (1997b) Expression of apoptosis-suppressing gene bcl-2 in human carotid body tumours. Journal of Pathology, 183, 218-221.
113. Wang, D.G., Johnston, C.F. & Buchanan, K.D. (1997c) Oncogene expression in gastroenteropancreatic neuroendocrine tumours. Implications for Pathogenesis. Cancer, 80, 668-675.
114. Wang, D.G., Johnston, C.F., Sloan, J.M. & Buchanan, K.D. (1998a) Bcl-2 expression in neuroendocrine tumour of lung: comparison with p53. Journal of Pathology, 184, 247-251.
115. Wang, D.G., Liu, W.H., Johnston, C.F., Sloan, J.M. & Buchanan, K.D. (1998b) Bcl-2 and c-Myc, but not Bax and p53 are expressed during human medullary thyroid tumourigenesis. American Journal of Pathology, 152, 1407-1413.
116. Williams, G.T. & Smith, C.A. (1993) Molecular regulation of apoptosis: genetic controls on cell death. Cell, 74, 777-779.
117. Wolfe, H.J., Melvin, K.E.W., Cervi-Skinner, S.J., Saadi, A.A.A., Juliar, J.F., Jackson, C.E. & Tashkian, A.H. (1973) C-cell hyperplasia preceding medullary thyroid carcinoma. New England Journal of Medicine, 289, 437-441.
118. Yana, I., Nakamura, T., Shin, E., Karakawa, K., Kurahashi, H., Kurita, Y., Kobayashi, T., Mori, T., Nishisho, I. & Takai, S. (1992) Inactivation of the p53 gene is not required for tumorigensis of medulary thyroid carcinoma or phaeochromocytoma. Japanese Journal of Cancer Research, 83, 1113-1116.
119. Yang, E. & Korsmeyer, S.J. (1996) Molecular thanatopsis: a discourse on the bcl-2 family and cell death. Blood, 88, 386-401.
120. Yoshimoto, K., Iwahana, H., Fukuda, A., Sano, T., Saito, S. & Itakura, M. (1992) Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerise chain reaction-single strand conformation polymorphism. Cancer Research, 52, 5061-5064.
121. Yuan, J. Y. & Horvitz, R.H. (1990) Genetic mosaic analysis ced-3 and ced-4, two genes that control programmed cell death in the nematode C. elegans. Developmental Biology, 138, 33-41.
122. Zhuang, Z., Ezzat, S.Z., Vorneyer, A.O., Well, R., Oldfield, E.H., Park, W.S., Pack, S., Huang, S., Agarwal, S.K., Gurn, S.S., Manickam, P., Debelenko, L.V., Kester, M.B., Olufemi, S.E., Heppner, C., Crabtree, J.S., Burn, A.L., Spiegel, A.M., Marx, S.J., Chandrasekharappa, S.C., Collins, F.S., Emmert-Buck, M.R., Liotta, L.A., Asa, S.L. & Lubensky, I.A. (1997) Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Research, 57, 5446-5451.
123. Zou, H., Henzel, W.J., Liu, X., Lutscha, A. & Wang, X. (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell, 90, 405-413.